Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Healthcare Professionals / OncoLink Scientific Meetings Coverage / PTCOG / OncoLink at PTCOG 2011 / PTCOG May 12, 2011
OncoLink reporters provide up-to-date coverage of the annual Particle Therapy Cooperative Group (PTCOG 50) meeting in Philadelphia, PA, May 8-14, 2011.
|
External beam radiation therapy continues to maintain pediatric Retinoblastoma
Presenter: Andrew L. Chang, David Andolino, Hiral Fontanilla, Anita Mahajan Presenter's Institution: Indiana University Proton Therapy Cancer Center and M.D. Anderson Proton Therapy Center Background/Introduction Retinoblastoma is a... |
|
|
Proton beam therapy for retroperitoneal neuroblastoma
Presenter: Hiroshi Fuji, M.D. Background/Introduction Neuroblastoma is the most common extracranial solid tumor malignancy in children and the most common malignancy in infants less than 1 year old. Neuroblastoma most commonly arises in the... |
|
|
Proton Therapy for Craniopharyngioma
Presenter: Andrew Chang, MD Presenter's Affiliation: Indiana University, Bloomington Proton Center Background Cranipharyngiomas are benign intracranial tumors arising from Rathke’s pouch in the sellar region. They often have a solid... |
|
|
Respiratory Liver Motion Extraction for Proton Therapy with Active Scanning Beam Delivery by Deformable Registration
Presenter: Ye Zhang1,2, Antje-Christin Knopf1,Dirk Boye1, Tony Lomax1 Presenter's Institution: Center for Proton Therapy, Paul Scherrer Institut, Switzerland and Computer Vision Laboratory, ETH Zurich, Switzerland Background/Introduction ... |
|
|
Spot-Scanning based proton radiation therapy for pediatric ependymoma: clinical outcome of 25 patients treated at Paul Scherrer Institute (PSI)
Presenter: Ares, C. Presenter's Affiliation: Center for Proton Therapy, Paul Scherrer Institute (PSI), Switzerland Background Ependymomas are rare brain tumors that occur in young children. They arise from ependymal cells which form... |
|
|
Use of robots to improve patients' treatment and throughput
Presenter: Regis Ferrand Presenter's Affiliation: Institut Curie-Centre de Protontherapie d'Orsay Presentation/Overview The purpose of this presentation was to provide an overview of the 15-20 year history of the use of robotic couches at... |
Ms. Nibauer-Cohen talks about how yoga can help people with cancer cope with the stresses of the diagnosis. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)


